Rheumatology (Oxford) 2022 Nov 02
While our understanding of the biologics safety in breastfeeding is still evolving and data is limited, based on my literature review, there are no signals that Belimumab is associated with an increased risk of adverse events in pregnancy/breastfeeding. Belimumab is a relatively large molecule, ther...